RAC 1.11% $1.83 race oncology ltd

Ann: RC220 Peripheral Infusion Safety Confirmed, page-18

  1. 342 Posts.
    lightbulb Created with Sketch. 94
    I reckon big pharma would be happy to buy now. This has de-risked RACE hugely.

    Are there any other steps we need to take for RC220 to be used in human trials (approvals etc)?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.